RepliCel Terminates License Agreement with Shiseido

[FilthyFrancis]

do You really think that the stock Price will dip If Shiseido Loses the rights For RCH-01? Most of their shareholders don’t Even know this technology…

Sorry I missed this one. You wouldn't guess how dumb the stock market can be when it comes to processing information.

I am not saying such piece of news could cause a massive dip but -3/5% which is painful enough,

Not an expert of the pharmaceutical industry though.

 

[79BirdofPrey]

I hope everyone is refreshed from the holiday break!

Is there any further information on this?
Are the phase 2 trial results published anywhere (were they promising or not)?

 

[Milkonos]

Phase 2 trials will end by end of 2022 IIRC

 

[Ralph Wiggum]

I'm not sure how relevant this is, but there was an update from Replicel on Twitter today:

Brief update: we have data pouring in from 3 different programs testing our
@DermaPrecise with all kinds of injectables, materials, and specifications. This is helping us narrow down most ideal applications for market launch and FDA submissions.

We are nearly finished preparations on an Early Adopter Program for Key Opinion Leaders in three continents for pre-clinical and clinical evaluations in different applications.
@DermaPrecise
#dermalinjector #dermalinjection More details announced

 

[RolfLeeBuckler]

I'm not sure how relevant this is, but there was an update from Replicel on Twitter today:

Brief update: we have data pouring in from 3 different programs testing our
@DermaPrecise with all kinds of injectables, materials, and specifications. This is helping us narrow down most ideal applications for market launch and FDA submissions.

We are nearly finished preparations on an Early Adopter Program for Key Opinion Leaders in three continents for pre-clinical and clinical evaluations in different applications.
@DermaPrecise
#dermalinjector #dermalinjection More details announced

this isnt directly related to RCH-01 because for example Shiseido Doesnt Use this dermaprecise to inject cells.
But of course the DermaPrecise would increase the results by using it.

These Are great News For the company Replicel as they Can bring their First product to the market